CClinicalTrials.gg
CompletedNCT05851612Updated Nov 25, 2024

Comparison of Three Methods of PEEP Titration During One Lung Ventilation in Prone Position

An interventional study of constant PEEP and Driving pressure guided PEEP in One Lung Ventilation, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-11-25.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

One-lung ventilation and prone positioning during thoracoscopic esophagectomy is associated with pulmonary complications so lung protection is strongly recommended. Individualization the optimal PEEP level according to the respira¬tory condition of patients has gradually attracted the attention of clinicians. The aim of this study is to compare and evaluate the differences between three different PEEP values in patients who will undergo thoracoscopic esophagectomy receiving either constant PEEP or driving pressure guided individualized PEEP or oxygenation guided individualized PEEP.

Read the detailed description

Induction of general anesthesia and mechanical ventilation impair respiratory function because of alveoli collapse, decreased functional residual capacity, diminished arterial oxygenation, and even mechanical ventilation-induced injury.In addition, One-lung ventilation during thoracic surgery is prone to ventilator induced lung injury and oxygen toxicity. It is also associated with a profound inflammatory cytokine release which causes excessive neutrophils recruitment that increases pulmonary vascular permeability in both lungs. These reactions often precede systemic inflammatory response syndrome, acute respiratory distress syndrome and pneumonia. Therefore, lung protection and protective ventilation is strongly recommended during thoracic surgery.In contrast to the lateral decubitus position, OLV in the prone position is devoid of the beneficial effect of gravity on preferential redistribution of the pulmonary blood flow to the dependent areas of a lung, possibly resulting in increased V/Q mismatch. Also, the prone position is frequently associated with decreased respiratory compliance and increased peak airway pressure in anesthetized and paralyzed patients when not assuring free abdominal and chest movements, which is further aggravated by CO2 insufflation. Prone positioning during esophagectomy provides several advantages, including shortened operative times and superior surgical view, at the cost of one-lung ventilation (OLV). Intraoperative lung protective ventilation strategy, which includes the combination of low tidal volume and adequate PEEP levels during operation, has been reported to improve respiratory mechanics and reduce the incidence and severity of atelectasis which may prolong hospital stays and increase mortality in surgical patients.Improper PEEP levels have an impact on patient physiology. If the setting level is too low to achieve the desired purpose, it cannot produce the effect of applying PEEP. If the setting level is too high, the pulmonary vascular resistance increases, venous return blood volume decreases, intrapulmonary shunt increases, and arterial oxygen partial pressure level is reduced. Also, it could negatively affect cardiac output and delivery of oxygen to vital organs.Individualization the optimal PEEP level according to the respira¬tory condition of patients has gradually attracted the attention of clinicians. The methods to determine the best PEEP levels include computed tomography scanning, electri¬cal impedance tomography, ultrasound, P-V curve method, best oxygenation titration method, and best lung compliance titration method. Each method has its advantages and disadvantages. Individualized PEEP has advantages over fixed PEEP in improved respiratory mechanics and prevent progressive alveolar collapse.There are few studies on the selection of appropriate PEEP values during one-lung ven¬tilation (OLV) in prone position and the protective effect of PEEP values can be titrated by different titration methods which still requires many prospective studies. Therefore, this study will be conducted to compare PEEP titration using driving pressure versus oxygenation method versus constant PEEP and evaluate their efficacy on oxygenation, ventilation, hemodynamics and PPC for patients undergoing thoracoscopic esophagectomy treated with one lung ventilation in prone position.

Aim of the Study:

The aim of this study is to compare and evaluate the differences between three different PEEP values in patients who will undergo thoracoscopic esophagectomy treated with one lung ventilation in prone position receiving either constant PEEP or driving pressure guided individualized PEEP or oxygenation guided individualized PEEP.

It is hypothesized that the individualized PEEP guided by driving pressure could improve intraoperative oxygenation function, pulmonary mechanics, early postoperative atelectasis, and reduce the incidence of postoperative pulmonary complications(PPCs) for patients undergoing thoracoscopic esophagectomy treated with one lung ventilation in prone position.

Sample Size Calculation:

A pilot study was performed to measure the lung ultrasound score at the end of the surgery to estimate the sample size. Sample size calculations were performed using G. power software (version 3.1.9.7). The means and standard deviations for the D group, O group, and C group were 10.5 + 2.02, 11.7 + 1.2, and 12.5 + 2.5, respectively. Sample size calculations showed that 11 subjects per group will be required to achieve 95% power with a Type I error of 0.05. A total of 42 patients (14 patients per group) will be included in this trial considering an 80% adherence rate.

Methods:

The study will include 42 patients who will be scheduled for thoracoscopic esophagectomy treated with one lung ventilation in prone position under general anesthesia. It will be conducted in Mansoura gastroenterology center over one year and patients will be recruited in june 2023. they will be randomly assigned to 3 equal groups (D group, O group and C group) according to computer-generated table of random numbers using the permuted block randomization method. The group allocation will be concealed in sequentially numbered, sealed opaque envelopes which will be opened only after obtaining the written informed consent.A single investigator will assess the patients for eligibility, obtain written informed consent, open the sealed opaque envelopes containing group allocation and set up the ventilator as specified in the envelope. The study subjects and the resident assessing the outcome will be blinded to the study group.The study protocol will be explained to all patients after enrollment into the study. They will be kept fasting according to pre-operative ASA recommendations prior to surgery. Basic demographic characters including age, sex, and BMI will be recorded. The peri-operative management will be identical in the three groups.

Statistical analysis:- The collected data will be coded, processed, and analyzed using Statistical Package for the Social Sciences (SPSS) program (version 22) for Windows. Normality of numerical data distribution will be tested by Kolmogorov-Smirnov test. Normally distributed numerical data will be presented as mean and standard deviation, and their comparison in different groups will be performed using one-way ANOVA with post-hoc Bonferroni test. Non-normally distributed numerical data will be presented as median and range, and compared nonparametrically using Kruskal-Wallis test followed by Mann-Whitney U test. Categorical data will be presented as number and percentage, and their comparison will be performed using Chi-square test. The all data will be considered significant if P value is ≤ 0.05.

02

Conditions studied

  • One Lung Ventilation

Keywords

  • optimal PEEP -one lung ventilation-prone position
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 182 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiology (ASA) (grade 1or 2) patients.
  • Scheduled for elective thoracoscopic esophagectomy treated with one lung ventilation in prone position and surgery of expected duration greater than 1 h.
  • Body mass index (BMI) less than 30 kg/m2.

Exclusion criteria

Exclusion Criteria:

  • Patient's refusal.
  • Altered mental status or un-cooperative patients.
  • History of known sensitivity to the used anesthetics.
  • Significant cardiac dysfunction, hepatic, or renal impairment.
  • History of severe chronic obstructive pulmonary disease.
  • History of severe or uncontrolled bronchial asthma.
  • History of severe restrictive lung disease.
  • History of pulmonary metastases.
  • History of any thoracic surgery.
  • Need for chest drainage prior to surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
42 participants (actual)

Study arms

  • Active comparator
    group C(constant group)

    Constant PEEP of 5 centimeter of water (cm H2O) will be applied

    Procedure: constant PEEP

  • Active comparator
    group D (driving group)

    PEEP titration will be according to driving pressure

    Procedure: Driving pressure guided PEEP

  • Active comparator
    group O (oxygenation group)

    PEEP titration will be according to oxygenation method

    Procedure: oxygenation method guided PEEP

Interventions

  • Procedureconstant PEEP

    Constant PEEP of 5 cm H2O will be applied and maintained throughout one-lung ventilation.

  • ProcedureDriving pressure guided PEEP

    PEEP titration will be started at 5 cmH2O and then increased in 1 cmH2O interval to 10 cmH2O. After 10 breath cycles will maintained, Driving pressure (ΔP) will be measured at each PEEP level at the last cycle. The PEEP indicating the lowest ΔP will be selected if multiple levels of PEEP showed the same lowest ΔP, the lowest PEEP will be selected. Driving pressure will be calculated as plateau pressure minus PEEP. Titration will stopped if peak inspiratory pressure of 50 cm H2O, or plateau pressure of 40 cm H2O reached, or hypotension will be observed.

  • Procedureoxygenation method guided PEEP

    PEEP titration will be started from 5 cmH2O and increase of 1 cmH2O every 4 min with fixed driving pressure that will result in delivery of a fixed tidal volume (TV) of 6ml/kg ideal body weight (IBW). Optimal PEEP will be defined as the PEEP below which PaO2 /FIO2 falls by at least 20%. If at least 20% PaO2 /FIO2 decrement is not obtained, then PEEP that will result in the highest PaO2 will be selected.

06

What researchers measure

Primary outcomes

  1. lung ultrasound score

    Thorax will be divided into 12 segments. The lung ultrasound score is 0 to 3, based on the B-line count and the degree of subpleural solidity. A total score of 0-36 will be obtained by summing the scores of the 12 segments. The absolute difference in the three lung ultrasound scores measured before induction, before neuromuscular block reversal, at the end of surgery/before extubation, and 5 min before leaving the PACU respectively.

    Time frame: Up to 5 min before leaving the post anesthesia care unit (PACU)

Secondary outcomes

  1. Positive end-expiratory pressure (PEEP)

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  2. The ratio of partial pressure of oxygen in arterial blood to the fraction of inspiratory oxygen concentration (PaO2/FiO2 ratio)

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  3. Heart rate (HR)

    It will be recorded before the procedure, after 15 min, 30 minutes and then every 30min intraoperative till the end of surgery.

    Time frame: Up to the end of the procedure

  4. The Central venous pressure (CVP) values

    It will be recorded before the procedure, after 15 min, 30 minutes and then every 30min intraoperative till the end of surgery.

    Time frame: Up to the end of the procedure

  5. The total volume of fluids and vasopressors administered

    They will be recorded at the end of surgery

    Time frame: Up to the end of the procedure

  6. The duration of operation, anesthesia and one lung ventilation .

    will be recorded at the end of surgery

    Time frame: Up to the end of the procedure

  7. Occurrence of Intra-operative adverse effects

    Any adverse events occur intraoperative as hypotension or bradycardia will be recorded.

    Time frame: Up to the end of the procedure

  8. Plateau pressure

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  9. Driving pressure

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  10. Tidal volume

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  11. Static compliance

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  12. Peak pressure

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  13. End-tidal carbon dioxide

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  14. Oxygen saturation

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  15. The alveolar-arterial gradient (A-a gradient)

    It will be collected at 10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  16. the potential of hydrogen (pH)

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  17. The partial pressure of carbon dioxide in arterial blood(PaCO2)

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  18. the partial pressure of oxygen n arterial blood(PaO2)

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  19. Actual base excess

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  20. Bicarbonate (HCO3)

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  21. Lactate

    It will be collected at before induction ,10 minutes after induction, Prone position, 10 minutes after titration and every hour until the end of OLV, before neuromuscular block reversal and at the end of surgery/before extubation.

    Time frame: Up to the end of the procedure

  22. Mean arterial blood pressure (MAP)

    It will be recorded before the procedure, after 15 min, 30 minutes and then every 30min intraoperative till the end of surgery.

    Time frame: Up to the end of the procedure

  23. Occurrence of post-operative complications.

    the occurrence of PPC (cough, increased sputum, dyspnea, chest pain, temperature above 38 °C, HR \> 100 beats/min) will be recorded.

    Time frame: up to one week after the procedure

07

Study locations

1 site
  • Mansoura University
    Mansoura, 35511, Egypt
08

References and documents

Publications

  • Choi YS, Shim JK, Na S, Hong SB, Hong YW, Oh YJ. Pressure-controlled versus volume-controlled ventilation during one-lung ventilation in the prone position for robot-assisted esophagectomy. Surg Endosc. 2009 Oct;23(10):2286-91. doi: 10.1007/s00464-008-0310-5. Epub 2009 Jan 30. PubMed 19184209 ↗
  • Wang ZY, Ye SS, Fan Y, Shi CY, Wu HF, Miao CH, Zhou D. Individualized positive end-expiratory pressure with and without recruitment maneuvers in obese patients during bariatric surgery. Kaohsiung J Med Sci. 2022 Sep;38(9):858-868. doi: 10.1002/kjm2.12576. Epub 2022 Jul 22. PubMed 35866347 ↗
  • Park M, Ahn HJ, Kim JA, Yang M, Heo BY, Choi JW, Kim YR, Lee SH, Jeong H, Choi SJ, Song IS. Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial. Anesthesiology. 2019 Mar;130(3):385-393. doi: 10.1097/ALN.0000000000002600. PubMed 30664548 ↗
  • Yao W, Yang B, Wang W, Han Q, Liu F, Shan S, Wang C, Zheng M. Effect of Positive End-Expiratory Pressure (PEEP) Titration in Elderly Patients Undergoing Lobectomy. Med Sci Monit. 2022 Dec 13;28:e938225. doi: 10.12659/MSM.938225. PubMed 36510453 ↗
  • Liu K, Huang C, Xu M, Wu J, Frerichs I, Moeller K, Zhao Z. PEEP guided by electrical impedance tomography during one-lung ventilation in elderly patients undergoing thoracoscopic surgery. Ann Transl Med. 2019 Dec;7(23):757. doi: 10.21037/atm.2019.11.95. PubMed 32042773 ↗
  • Monastesse A, Girard F, Massicotte N, Chartrand-Lefebvre C, Girard M. Lung Ultrasonography for the Assessment of Perioperative Atelectasis: A Pilot Feasibility Study. Anesth Analg. 2017 Feb;124(2):494-504. doi: 10.1213/ANE.0000000000001603. PubMed 27669555 ↗
  • Xu Q, Guo X, Liu J, Li SX, Ma HR, Wang FX, Lin JY. Effects of dynamic individualized PEEP guided by driving pressure in laparoscopic surgery on postoperative atelectasis in elderly patients: a prospective randomized controlled trial. BMC Anesthesiol. 2022 Mar 16;22(1):72. doi: 10.1186/s12871-022-01613-9. PubMed 35296253 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05851612
Lead sponsor
Mansoura University
Responsible party
Amany Hazem abdelmaksood EL-deeb (Lecturer of anesthesia, ICU & pain management; Faculty of Medicine, Mansoura University) — Principal investigator
First posted
May 9, 2023
Start date
Jun 5, 2023
Primary completion
Oct 10, 2024
Completion
Nov 21, 2024
Last update
Nov 25, 2024

Study contacts

Amany EL-Deeb, MD
principal investigator · Faculty of Medicine, Mansoura University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion